The global home infusion therapy market size was valued at USD 53.39 billion in 2025 and is projected to surpass around USD 119.61 billion by 2035, registering a CAGR of 8.4% over the forecast period of 2026 to 2035.
The home infusion therapy market is characterized by the provision of medical treatments administered at patients' homes rather than in traditional healthcare settings. This approach offers convenience, comfort, and cost-effectiveness, making it increasingly popular among patients with chronic illnesses. Home infusion therapy encompasses a range of treatments, including intravenous medications, antibiotics, hydration therapy, and parenteral nutrition, among others. Technological advancements in infusion devices and healthcare delivery systems have facilitated the growth of this market, making it easier for patients to receive complex treatments safely at home. Additionally, the rising prevalence of chronic diseases, aging population, and the desire for personalized healthcare experiences contribute to the expansion of the home infusion therapy market. Overall, this market trend reflects a shift towards patient-centered care and the growing importance of home-based healthcare solutions.
AI and ML are revolutionizing the home infusion therapy industry by enabling contunious remote patient monitoring and automated dose adjustments. These smart technologies provide predictive analytics to detect health deterioration or equipment anomalies before they become critical, significantly improving patient safety without requiring frequent hospital visits. Machine learning algorithms tailor therapy to individual needs by processing real-time physiological data, which optimizes drug delivery and ensures strict medication adherence. By automating administrative tasks and dynamic scheduling, AI significantly reduces the operational burden on clinical staff while expanding access to highly precise at-home care.
While anti-infectives historically held the largest share, treatments are rapidly expanding into complex, long-term conditions. Chemotherapy and specialty pharmaceuticals are now witnessing rising cancer rates and new drug developments.
The development of smart, lightweight, and ambulatory infusion pumps enables continuous and precise medication delivery in residential settings. These user-friendly devices include safety features, such as dosage error alarms and automatic flow controls to maximize patient safety at home.
The incorporation of digital health tools, remote monitoring, and telehealth platforms allows healthcare professionals to track patient progress in real-time. Providers can increasingly share data, monitor drug administration adherence, and intervene quickly if technical or medical complications arise.
| Report Attribute | Details |
| Market Size in 2026 | USD 57.87 Billion |
| Market Size by 2035 | USD 119.61 Billion |
| Growth Rate From 2026 to 2035 | CAGR of 8.4% |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Product, Application, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Key Companies Profiled | CVS/Coram; Option Care Health; BriovaRx/Diplomat (UnitedHealth Optum); PharMerica; Fresenius Kabi; ICU Medical, Inc.; B. Braun Melsungen AG; Baxter; BD; Caesarea Medical Electronics; Smiths Medical; Terumo Corporation; JMS Co. Ltd. |
The infusion pumps segment accounted for the largest revenue share of over 52% in 2025. Infusion pumps, designed for controlled delivery of fluids, medications, and nutrients, were initially exclusive to healthcare facilities but are now widely adopted in outpatient settings. These devices ensure precision, reducing medication errors. The surge in home healthcare has driven the demand for syringe and ambulatory pumps. Smart pumps, featuring barcode technology, enhance patient identity verification, preventing administration errors. These pumps also provide alerts to healthcare workers in case of inappropriate dosage selection. The introduction of advanced infusion pumps, like the CADD-Solis ambulatory infusion pump by Smiths Medical, is expected to propel market growth in the forecast period.
Needleless connectors are anticipated to register the highest CAGR over the forecast period. Needless connectors are small devices employed in intravenous systems to reduce needlestick injuries, thereby preventing bacterial contamination and improving safety. These devices are evaluated on the basis of interstitial surface mechanisms, blood refluxes, visibility, and external surface mechanisms. Needless connectors enable smooth operative procedures, ensure safety, and aid in adhering to clinical practices.
The anti-infective segment dominated the market for home infusion therapy in 2025 with a revenue share of over 26.19%. This is attributed to the considerable number of procedures performed for the administration of antifungal and antibiotic drugs. It also helps reduce exposure to patients with other hospital-acquired infections (HAIs).
Chemotherapy is estimated to be the fastest-growing segment over the forecast period. With the growing incidences of cancer, the demand for pressure pumps is expected to increase in the coming years. Pumps used for chemotherapy at home are compact, continuous pressure pumps that do not require a battery and can hence be used for a longer period of time. With the help of these pumps, chemotherapy drugs can be administered at the appropriate infusion speed and in the right amounts.
North America dominated the market in 2025 with a revenue share of over 57% and this trend is expected to continue throughout the forecast period. This can be attributed to the increasing R&D in the region and the rising adoption of new technology in infusion pumps. The increasing need for long-term therapy for patients with certain conditions is driving the regional market. Development of alternate healthcare settings and home infusion services and shifting preference from acute care to home care settings due to the low cost and enhanced patient mobility would boost the growth of this market in the coming years.
U.S. Home Infusion Therapy Market Trends
The U.S. shift toward decentralized healthcare is structurally anchoring the growth of home infusion therapies, by the compelling cost-effectiveness of minimizing prolonged hospital stays through value-based care models. The intersecting dynamics are establishing home infusion as a critical, high-efficiency pillar of modern patient management.
The Asia Pacific market is expected to register the fastest CAGR over the forecast period. This is attributed to rising patient awareness regarding the benefits of home infusion therapy over in-hospital procedures and the growing prevalence of diabetes in the region. The growing geriatric population and the rise in chronic diseases in the region are expected to further fuel the market growth. According to the Times of India, around 75 million people over the age of 60 years suffer from some chronic disease in India, which might increase the adoption of home care services in the country.
China Home Infusion Therapy Market Trends
China’s structural shift toward decentralized, outpatient healthcare is driving sustainable volume growth for portable infusion pumps and speciality pharmaceuticals across major regional municipal hubs. The migration of complex oncology care out of overloaded clinical networks is positioning home-based chemotherapy and speciality biologics as premier growth segments. To secure clinical compliance in these residential environments, providers are aggressively integrating smart telemetry into delivery devices, enabling physicians to monitor patient drug adherence in real time.
How did Europe Hold A Notable Share in the Home Infusion Therapy Market?
Europe’s demographic shift toward an aging population across Western Europe is generating an unprecedented volume of chronic diseases, driving a sustained demand for long-term parenteral nutrition and advanced pain management solutions. This epidemiological pressure is heavily reinforced by supportive government initiatives and favorable reimbursement frameworks, which actively incentivize decentralized, outpatient care models to optimize public hospital capacity.
Germany Home Infusion Therapy Market Trends
Germany’s rapidly expanding home infusion market reflects a mature European healthcare ecosystem heavily supported by robust integration with both public and private reimbursement frameworks. While anti-infective therapies continue to command the highest baseline revenue share, the endocrinology segment is tracking the steepest growth trajectory due to an escalating demand for advanced diabetes and autoimmune treatments.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2035. For this study, Nova one advisor, Inc. has segmented the home infusion therapy market.
By Product
By Application
By Region
Home Infusion Therapy Market
Download Sample
Request Customization
Request Customization
Download Sample